These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35138548)

  • 1. NAFLD determined by Dallas Steatosis Index is associated with poor outcomes in COVID-19 pneumonia: a cohort study.
    Moctezuma-Velázquez P; Miranda-Zazueta G; Ortiz-Brizuela E; Garay-Mora JA; González-Lara MF; Tamez-Torres KM; Román-Montes CM; Díaz-Mejía BA; Pérez-García E; Villanueva-Reza M; Chapa-Ibargüengoitia M; Uscanga-Domínguez L; Sifuentes-Osornio J; Ponce-de-León A; Kershenobich-Stalnikowitz D; Mota-Ayala B; Moctezuma-Velázquez C
    Intern Emerg Med; 2022 Aug; 17(5):1355-1362. PubMed ID: 35138548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dallas Steatosis Index Identifies Patients With Nonalcoholic Fatty Liver Disease.
    McHenry S; Park Y; Browning JD; Sayuk G; Davidson NO
    Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2073-2080.e7. PubMed ID: 31982611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease with advanced fibrosis in the death and intubation of patients hospitalized with coronavirus disease 2019.
    Vázquez-Medina MU; Cerda-Reyes E; Galeana-Pavón A; López-Luna CE; Ramírez-Portillo PM; Ibañez-Cervantes G; Torres-Vázquez J; Vargas-De-León C
    Hepatol Commun; 2022 Aug; 6(8):2000-2010. PubMed ID: 35438253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19.
    Forlano R; Mullish BH; Mukherjee SK; Nathwani R; Harlow C; Crook P; Judge R; Soubieres A; Middleton P; Daunt A; Perez-Guzman P; Selvapatt N; Lemoine M; Dhar A; Thursz MR; Nayagam S; Manousou P
    PLoS One; 2020; 15(10):e0240400. PubMed ID: 33031439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19.
    Campos-Murguía A; Román-Calleja BM; Toledo-Coronado IV; González-Regueiro JA; Solís-Ortega AA; Kúsulas-Delint D; Cruz-Contreras M; Cruz-Yedra N; Cubero FJ; Nevzorova YA; Martínez-Cabrera CF; Moreno-Guillén P; Lozano-Cruz OA; Chapa-Ibargüengoitia M; Gulías-Herrero A; Aguilar-Salinas CA; Ruiz-Margáin A; Macías-Rodríguez RU
    Dig Liver Dis; 2021 May; 53(5):525-533. PubMed ID: 33551355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Associated Fatty Liver Disease Is Associated With an Increased Risk of Severe COVID-19: A Systematic Review With Meta-Analysis.
    Hegyi PJ; Váncsa S; Ocskay K; Dembrovszky F; Kiss S; Farkas N; Erőss B; Szakács Z; Hegyi P; Pár G
    Front Med (Lausanne); 2021; 8():626425. PubMed ID: 33777974
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic performance of an index based on lactic dehydrogenase and transaminases for patients with liver steatosis and COVID-19.
    Macías-Rodríguez RU; Solís-Ortega AA; Ornelas-Arroyo VJ; Ruiz-Margáin A; González-Huezo MS; Urdiales-Morán NA; Román-Calleja BM; Mayorquín-Aguilar JM; González-Regueiro JA; Campos-Murguía A; Toledo-Coronado IV; Chapa-Ibargüengoitia M; Valencia-Peña B; Martínez-Cabrera CF; Flores-García NC
    World J Gastroenterol; 2022 Oct; 28(37):5444-5456. PubMed ID: 36312835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients: what do we know so far ?
    Binet Q; Loumaye A; Preumont V; Thissen JP; Hermans MP; Lanthier N
    Acta Gastroenterol Belg; 2022; 85(2):346-357. PubMed ID: 35709779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort.
    Yoo HW; Jin HY; Yon DK; Effenberger M; Shin YH; Kim SY; Yang JM; Kim MS; Koyanagi A; Jacob L; Smith L; Yoo IK; Shin JI; Lee SW
    J Korean Med Sci; 2021 Oct; 36(41):e291. PubMed ID: 34697932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Fatty Liver Associated with Increased Mortality and Morbidity in Coronavirus Disease 2019 (COVID-19) Pneumonia?
    Madan K; Rastogi R; Bhargava R; Dagar V; Singla V; Sahu A; Singh P; Garg P; Aggarwal B; Singh RK
    J Clin Exp Hepatol; 2022; 12(5):1320-1327. PubMed ID: 35469129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the fatty liver index and the risk of severe complications in COVID-19 patients: a nationwide retrospective cohort study.
    Chang Y; Jeon J; Song TJ; Kim J
    BMC Infect Dis; 2022 Apr; 22(1):384. PubMed ID: 35430797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID-19 Infection.
    Younossi ZM; Stepanova M; Lam B; Cable R; Felix S; Jeffers T; Younossi E; Pham H; Srishord M; Austin P; Estep M; Terra K; Escheik C; de Avila L; Golabi P; Kolacevski A; Racila A; Henry L; Gerber L
    Hepatol Commun; 2022 Nov; 6(11):3062-3072. PubMed ID: 34558853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease.
    Moon JH; Kim W; Koo BK; Cho NH;
    Gut Liver; 2022 May; 16(3):433-442. PubMed ID: 34635626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan.
    Yoneda M; Yamamoto T; Honda Y; Imajo K; Ogawa Y; Kessoku T; Kobayashi T; Nogami A; Higurashi T; Kato S; Hosono K; Saito S; Nakajima A
    J Gastroenterol; 2021 Nov; 56(11):1022-1032. PubMed ID: 34601620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States.
    Kim D; Konyn P; Sandhu KK; Dennis BB; Cheung AC; Ahmed A
    J Hepatol; 2021 Dec; 75(6):1284-1291. PubMed ID: 34380057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hepatic steatosis on COVID-19 severity: Chest computed tomography findings.
    Parlak S; Çıvgın E; Beşler MS; Kayıpmaz AE
    Saudi J Gastroenterol; 2021; 27(2):105-110. PubMed ID: 33642355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes.
    Lee S; Bae J; Jo DR; Lee M; Lee YH; Kang ES; Cha BS; Lee BW
    Front Endocrinol (Lausanne); 2023; 14():1124576. PubMed ID: 36896171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
    Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
    J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity in patients with COVID-19: a systematic review and meta-analysis.
    Huang Y; Lu Y; Huang YM; Wang M; Ling W; Sui Y; Zhao HL
    Metabolism; 2020 Dec; 113():154378. PubMed ID: 33002478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.